Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 600 participants.

Also called NCT06360120

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 600 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06360120
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06360120. Randomized; double masking; primary purpose treatment. Start 2024-04-10 (actual); primary completion 2025-09-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke
Intervention (Drug)
Atorvastatin 40 Mg Oral Tablet
Intervention (Drug)
Rosuvastatin 20mg
Intervention (Drug)
Clopidogrel 75 Mg Oral Tablet
Intervention (Drug)
Clopidogrel 75 Mg Oral Tablet
Lead sponsor
Kafrelsheikh University (class: other)

Record details

Record id
cardio:ct-nct06360120
Content hash
a66bfe4f7008df41c37ec9d35675c7e6868b4054ab1bf39eb63a703fecf2e5cb